S. Sarker et al., NUCLEAR-DNA CONTENT OF FINE-NEEDLE ASPIRATES OF INVASIVE DUCTAL CARCINOMAS OF THE BREAST, Analytical cellular pathology, 13(1), 1997, pp. 1-8
Patients with aggressive breast cancers benefit from chemotherapy prio
r to surgery. If the biology of the breast cancers were better charact
erised pre-operatively, more patients at risk could be offered chemoth
erapy. We have assessed nuclear DNA content of fine needle aspirates (
FNA) of 103 invasive ductal breast cancers and compared this to tumour
size, node status and histological grade. Median follow-up was 18 mon
ths so no prognostic studies were made. Diploid and non-diploid tumour
s were distributed equally in node negative and positive patients. How
ever non-diploidy status increased in line with known prognostic marke
rs of tumour size and histological grade. This suggests that ploidy mi
ght contribute to the pre-operative assessment of prognosis. We conclu
de that nuclear DNA of breast cancer FNAs may be of value in the pre-o
perative biological assessment of breast cancer patients.